StockWatch
·
HomeLiveWeekly

Cardiff Oncology, Inc.

Ticker: 1213037

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-18.27-5.776.7319.23Q2 FY2023Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q2 FY2023Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025
PeriodQ3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024Q3 FY2023Q2 FY2023
INCOME
Revenue0.12+0.0%0.12+9.1%0.11-35.3%0.17+6.3%0.16-23.8%0.21+50.0%0.14+27.3%0.11
Total Income0.12+0.0%0.12+9.1%0.11-35.3%0.17+6.3%0.16-23.8%0.21+50.0%0.14+27.3%0.11
EXPENSES
Expenditure12.09-18.9%14.90+2.8%14.49+13.5%12.77+0.5%12.71+14.1%11.14+1.6%10.96-11.0%12.32
PROFIT
Net Profit-11.26+19.2%-13.94-3.8%-13.43-13.2%-11.86-0.7%-11.78-17.7%-10.01-2.9%-9.73+12.7%-11.15
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.17+19.0%-0.21-5.0%-0.20+20.0%-0.25+3.8%-0.26-18.2%-0.22+0.0%-0.22+12.0%-0.25

Corporate Events

Board MeetingCRDF
2026
6Apr

Board Meeting

Josh Muntner appointed Chief Financial Officer, Ajay Aggarwa…

SEC Filing ↗